General
Showing 1105–1120 of 1205 results
-
Article: The emerging role of stereotactic radiotherapy in oligometastatic cancer
€3.03 Only for registered clients -
Article: The evolving role of immunotherapy in the treatment paradigm for patients with small-cell lung cancer
€3.03 Only for registered clients -
Article: The evolving role of radiotherapy in the treatment of lung cancer
€3.03 Only for registered clients -
Article: The financial toxicity of cancer immunotherapy
€3.03 Only for registered clients -
Article: The first Belgian multidisciplinary meeting on urological cancers
€3.03 Only for registered clients -
Article: The gut microbiome: a predictive biomarker for a response to immune checkpoint inhibition?
€3.03 Only for registered clients -
Article: The hype of phase II trials
€3.03 Only for registered clients -
Article: The ideal cervical cancer screening recommendation for Belgium, an industrialised country in Europe
€3.03 Only for registered clients -
Article: The impact of sarcopenia in oncology Patients
€3.03 Only for registered clients -
Article: The ION-Ghent guidelines for the management of immune related adverse events (irAE’s)
€3.03 Only for registered clients -
Article: The management of nivolumab plus cabozantinib in the frontline treatment of advanced renal cell carcinoma
€3.03 Only for registered clients -
Article: The MSD Onco Award 2014: Effectiveness of Botulinum Toxin Infiltration for treatment of upper limb dysfunctions after breast cancer
€3.03 Only for registered clients -
Article: The potential of proton therapy in oesophageal cancer treatment
€3.03 Only for registered clients -
Article: The potential role of patient advocates
€3.03 Only for registered clients -
Article: The prognostic significance of disseminated tumour cells in bone marrow in patients with operable breast cancer: An updated analysis
€3.03 Only for registered clients -
Article: The RANK ligand inhibitor denosumab as novel therapeutic agent in the spectrum of cancer bone disease
€3.03 Only for registered clients